NCT05801549

Brief Summary

We wish to examine Arterio-Venous Fistula (AVF) and Arterio-Venous Graft (AVG) utilisation rates for Haemodialysis at University Hospital Limerick. We want to determine out of the AVF's that are surgically created, how many go on to be used as anticipated for haemodialysis treatments successfully.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 13, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 23, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 6, 2023

Completed
Last Updated

April 6, 2023

Status Verified

April 1, 2023

Enrollment Period

3 months

First QC Date

March 23, 2023

Last Update Submit

April 5, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of AVF's created

    We will determine how many were created surgically during the time frame.

    3 years

Secondary Outcomes (1)

  • AVF's in use for the purpose of Haemodialysis

    3 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients who had an AVF or AVG surgically created over the last three years at UHL who are undergoing haemodialysis treatments are suitable for inclusion. Dates for audit purposes are 1st April 2019 to 1st April 2022.

You may qualify if:

  • Dates for audit purposes are 1st April 2019 to 1st April 2022.

You may not qualify if:

  • Patients outside of these set dates will be excluded.
  • Patients who are not currently undergoing haemodialysis treatments are excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Limerick

Limerick, Ireland

Location

Related Publications (1)

  • Colley, E., Carroll, J., Anne, S., Shannon, T., Ramon, V. and Tracie, B. (2022). A longitudinal study of the arterio-venous fistula maturation of a single patient over 15 weeks. Biomechanics and Modeling in Mechanobiology, pp.1-16. Dixon, B.S. (2006). Why don't fistulas mature? Kidney International, 70 (8): pp1413-1422. Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H.M., Okpechi, I., Zhao, M.H., Lv, J., Garg, A.X., Knight, J. and Rodgers, A. (2015). Worldwide access to treatment for end-stage kidney disease: a systematic review. The Lancet, 385 (9981), pp.1975-1982.

    BACKGROUND

MeSH Terms

Conditions

Arteriovenous Fistula

Condition Hierarchy (Ancestors)

Arteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
CNM II Research

Study Record Dates

First Submitted

March 23, 2023

First Posted

April 6, 2023

Study Start

September 13, 2022

Primary Completion

December 9, 2022

Study Completion

January 10, 2023

Last Updated

April 6, 2023

Record last verified: 2023-04

Locations